Stay updated on TRuE AD1 Clinical Trial
Sign up to get notified when there's something new on the TRuE AD1 Clinical Trial page.

Latest updates to the TRuE AD1 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe Locations section has been updated with additional study sites across several states and countries. This expands the list of participating locations.SummaryDifference0.2%

- Check33 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference1%

- Check40 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed; no substantive changes to core content, pricing, stock, or time-slot information.SummaryDifference0.1%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check68 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations across Germany and Poland, as well as new research references related to Ruxolitinib cream for atopic dermatitis. Notably, previous location terms and related topics have been removed.SummaryDifference4%

Stay in the know with updates to TRuE AD1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRuE AD1 Clinical Trial page.